Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009028
Filing Date
2022-05-10
Accepted
2022-05-10 16:40:00
Documents
78
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20220331.htm   iXBRL 10-Q 2540008
2 EX-3.1 bior-ex3_1.htm EX-3.1 16287
3 EX-3.2 bior-ex3_2.htm EX-3.2 229771
4 EX-31.1 bior-ex31_1.htm EX-31.1 20127
5 EX-31.2 bior-ex31_2.htm EX-31.2 20439
6 EX-32.1 bior-ex32_1.htm EX-32.1 16473
  Complete submission text file 0000950170-22-009028.txt   10267707

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bior-20220331.xsd EX-101.SCH 77196
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bior-20220331_pre.xml EX-101.PRE 490163
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bior-20220331_lab.xml EX-101.LAB 651765
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bior-20220331_cal.xml EX-101.CAL 69957
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bior-20220331_def.xml EX-101.DEF 315565
72 EXTRACTED XBRL INSTANCE DOCUMENT bior-20220331_htm.xml XML 1655775
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 22910487
SIC: 8071 Services-Medical Laboratories